Ascend Capital’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$8.01M Sell
126,324
-101,143
-44% -$6.55M 0.4% 77
2018
Q2
$13.3M Buy
227,467
+45,872
+25% +$2.49M 0.63% 54
2018
Q1
$9.3M Buy
181,595
+51,906
+40% +$2.78M 0.38% 88
2017
Q4
$7.72M Buy
+129,689
New +$7.87M 0.29% 98
2017
Q3
Sell
-89,475
Closed -$4.99M 207
2017
Q2
$4.99M Sell
89,475
-290,173
-76% -$16M 0.23% 113
2017
Q1
$19.5M Buy
379,648
+83,097
+28% +$4.08M 0.88% 44
2016
Q4
$13.3M Buy
+296,551
New +$13.1M 0.66% 57

Other funds holding CONE

Ascend Capital's CONE Position: Q3 2018 in Review

Ascend Capital reduced its CyrusOne Inc Common Stock (CONE) stake by 44% in Q3 2018, selling an estimated $6.55M and leaving 126,324 shares worth $8.01M. The position accounts for 0.4% of the portfolio, ranked #77.

Ascend Capital first reported a position in CONE in Q4 2016 and has held it in 7 quarters since. The position peaked at $19.5M in Q1 2017. 382 funds tracked by Wall St. Rank hold CONE as of Q3 2018.

  • Ascend Capital held 126,324 shares of CyrusOne Inc Common Stock worth $8.01M as of Q3 2018.
  • Ascend Capital sold 101,143 CyrusOne Inc Common Stock shares in Q3 2018, an estimated $6.55M.
  • CyrusOne Inc Common Stock made up 0.4% of Ascend Capital's portfolio in Q3 2018, its #77 holding.
  • Ascend Capital first reported a position in CyrusOne Inc Common Stock in Q4 2016 and has held it in 7 quarters since.
  • Ascend Capital's CyrusOne Inc Common Stock position peaked at $19.5M in Q1 2017.
  • 382 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.